Search

everythinglearnresearchcommunity

for

Search:↓

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

Dutasteride is more efficient than finasteride, but individual results vary.

Male pattern baldness involves hormones and cell signals affecting hair growth.

The document suggests more research is needed to understand the link between baldness and prostate cancer.

Gene variant linked to prostate cancer, hormone levels, and hair loss.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Dutasteride works better than finasteride for hair loss, with both being safe to use.

Both genes and environmental factors like chemicals may contribute to the increase in hypospadias, but the exact causes are still unclear.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

Early balding at 40 increases prostate cancer risk.

Androgens can both increase body hair and cause scalp hair loss.

Genetic differences within ethnic groups may affect prostate cancer treatment effectiveness.

Longer TA repeats in the SRD5A2 gene may increase acne risk in Chinese people.

Gene differences may affect baldness treatment response in Korean men.

No consistent link between genotype and phenotype in 5-α-Reductase type 2 deficiency.

Dutasteride is more effective than finasteride at increasing hair count and reversing hair thinning in men with hair loss, but both have similar side effects.